Helios Hospital Berlin-Buch

addBerlin, Germany
( 8/10 from votes )
Prof. Dr. Peter Reichardt

Head of the Department

Prof. Dr. Peter Reichardt

Department of Oncology

Department of Oncology at Helios Hospital Berlin-Buch provides care for patients with all types of cancerous tumors and malignancies. The department is a significant part of the Cancer Center Berlin-Buch and it works in close cooperation with other departments as well as specialists through this center. As a certified center by the German Cancer Society, the facility offers the full spectrum of therapeutic measures, such as antibody therapy, targeted therapy, complex chemotherapy, and regional deep hyperthermia alongside chemotherapy and radiation therapy. Under the guidance of Prof. Dr. Med. Peter Reichardt, the staff treats over 3,000 inpatients every year, many of which suffer from connective or soft tissue tumors. The medical team works hand in hand with the patients to develop a tailor-made appropriate management plan.
The Department of Oncology at Helios Hospital Berlin-Buch is specialized in the diagnosis and treatment of:

  • Brain tumors
  • Lung cancer
  • Stomach tumors
  • Malignant melanoma
  • Bone tumors
  • Soft tissue sarcomas
  • Liver cancer
  • Bile duct tumor
  • Metastases to thoracic organs
  • Metastases to abdominal organs
  • Neuroendocrine tumors

Education

  • 1977 - 1984 Study of Human Medicine in Stuttgart-Hohenheim and Heidelberg.
  • 1984 Admission to medical practice.
  • 1989 Doctoral thesis defense, magna cum laude.
  • 1991 Board certification in Internal Medicine.
  • 2000 European certification in Medical Oncology.
  • 2006 Habilitation and Venia legendi in Internal Medicine.
  • 2011 Board certification in Hematology and Oncology.
  • 2016 Qualified Medical Reviewer.

Professional Career

  • 1984 - 1991 Research Fellow in the Department of Internal Medicine V at the University Hospital Heidelberg.
  • 1985 Internship at the MD Anderson Cancer Center, Houston, Texas, USA.
  • 1991 Senior Physician, Department of Internal Medicine V at the University Hospital Heidelberg.
  • 1992 - 2003 Senior Physician, Department of Hematology, Oncology and Cancer Immunology, Robert Rössle Clinic, Charite University Hospital Berlin, Campus Virchow.
  • 2001 - 2003 Senior Physician, Department of Hematology and Oncology, University Hospital Charite Berlin, Campus Virchow.
  • 2003 - 2007 Senior Physician, Department of Hematology, Oncology and Cancer Immunology, Robert Rössle Clinic, Charite University Hospital Berlin, Campus Buch.
  • 2007 - 2014 Chief Physician of the Department of Hematology, Oncology and Palliative Care, Helios Hospital Bad Saarow, as well as Director of the Sarcoma Center Berlin-Brandenburg.
  • Since 2012 Chief Physician of the Department of Interdisciplinary Oncology, Helios Hospital Berlin-Buch.
  • Since 2014 Head of the Cancer Center Berlin-Buch.
  • Since 2016 Medical Director of the Helios Hospital Berlin-Buch; Member of the Research Board of the Helios Network, Regional Manager for Service Transparency of the Working Group of the Helios Network.

Memberships in Professional Societies and Organizations

  • American Society of Clinical Oncology (ASCO).
  • European Society of Medical Oncology (ESMO).
  • Connective Tissue Oncology Society (CTOS).
  • German Cancer Society.
  • M. D. Anderson Associates.
  • Working Group on Internal Oncology of the German Cancer Society.
  • German Society of Hematology and Oncology (DGHO).
  • Group on Soft Tissue and Bone Sarcoma of the European Organization for Research and Treatment of Cancer (EORTC).
  • Sarcoma Foundation of America.
  • Member of the Expanded Commission for Doctoral Thesis Assessment in Charite.
  • Member of the Guideline Commission for the Working Group on Soft Tissue and Bone Sarcoma, Association for Internal Oncology.
  • Chairman of the Lebenshaus Medical Advisory Board.
  • Member of the Guideline Commission for Soft Tissue, Bone Sarcoma, and GIST of the German Society of Hematology and Oncology.
  • Member of the European Society of Medical Oncology (ESMO).
  • Member of the Guideline Commission for Soft Tissue, Bone Sarcoma, and GIST of the European Society of Medical Oncology (ESMO).
  • Peer review activities in national and international journals.
  • Member of the Medical Board of the MAX Foundation.
  • Global Advisory Group on GIST Life Raft Group.